Official Summary

Digest: Tells insurers and PBMs not to require that drugs be labeled as 340B drugs in a claim for repayment. (Flesch Readability Score: 62.8). Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug. Takes effect on the 91st day following adjournment sine die.